Incyte | INCY - Eps Ganancias Por Acción


Fiscal Calendario Real Consenso Anterior Fecha
FY2026Q3 Sep/2025 1.98 2.26 Nov/03
FY2026Q2 Jun/2026 3.09 1.99 1.57 Jul/28
FY2026Q1 Mar/2026 1.81 1.42 1.16 Apr/28
FY2025Q4 Dec/2025 1.80 1.93 1.43 Feb/10
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28




Eps Cambio Fecha
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agenus USD 1.02 1.32 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Exelixis USD 0.87 0.1 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
MacroGenics USD -0.58 0.36 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 2.41 0.42 2026-06
Novartis USD 1.99 0.45 2026-03
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03